NEW YORK (GenomeWeb News) — Illumina and its Solexa subsidiary today said that they have filed a countersuit in response to a DNA sequencing patent-infringement lawsuit brought against them last month by Life Technologies and its subsidiary Applied Biosystems.

In their filing, Illumina and Solexa have denied all of Life's and ABI's allegations of patent infringement, and they have asserted that ABI's licensed patents are invalid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.